Phase I trial of expanded, activated autologous NK-cell infusions with trastuzumab in patients with HER2-positive cancers

Soo Chin Lee, Noriko Shimasaki, Joline S.J. Lim, Andrea Wong, Kritika Yadav, Wei Peng Yong, Lip Kun Tan, Liang Piu Koh, Michelle L.M. Poon, Sing Huang Tan, Samuel G.W. Ow, Lavina Bharwani, Yoon Sim Yap, Mabel Z.Q. Foo, Elaine Coustan-Smith, Raghav Sundar, Hon Lyn Tan, Wan Qin Chong, Nesaretnam Barr Kumarakulasinghe, Jedidah L.M. LieowPriscillia J.X. Koe, Boon Cher Goh, Dario Campana

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I trial of expanded, activated autologous NK-cell infusions with trastuzumab in patients with HER2-positive cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences